588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
gen3018 Acute Myeloid Leukemia	Genmab	P1	CC (43)
Hidac Acute Myeloid Leukemia	Syndax Pharmaceuticals	P1	CC (43)
Human Leukocyte Acute Myeloid Leukemia	Brown University	P2	CC (43)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Acute Myeloid Leukemia	Mayo Clinic	P1	CC (43)
Interferon Gamma-1B Acute Myeloid Leukemia	Sawa Ito, MD	P2	CC (43)
Jab-8263 Acute Myeloid Leukemia	Jacobio Pharmaceuticals Co., Ltd.	P1/2	CC (43)
kk2845_1 Acute Myeloid Leukemia	Kyowa Kirin Co., Ltd.	P1	CC (43)
kk2845_2 Acute Myeloid Leukemia	Kyowa Kirin Co., Ltd.	P1	CC (43)
kk2845_3 Acute Myeloid Leukemia	Kyowa Kirin Co., Ltd.	P1	CC (43)
kk2845_4 Acute Myeloid Leukemia	Kyowa Kirin Co., Ltd.	P1	CC (43)
kk2845_5 Acute Myeloid Leukemia	Kyowa Kirin Co., Ltd.	P1	CC (43)
kk2845_6 Acute Myeloid Leukemia	Kyowa Kirin Co., Ltd.	P1	CC (43)
Luspatercept Acute Myeloid Leukemia	National Cancer Institute (NCI)	P2	CC (43)
Memory-Like Natural Killer Cells Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CC (43)
mgd024 Acute Myeloid Leukemia	MacroGenics	P1	CC (43)
Mgta-456 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	CC (43)
Mir-126 Inhibitor Miristen Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
mk-0482 Acute Myeloid Leukemia	Merck Sharp & Dohme LLC	P1	CC (43)
mt-401-ots Acute Myeloid Leukemia	Marker Therapeutics, Inc.	P1	CC (43)
nc525 Acute Myeloid Leukemia	NextCure, Inc.	P1	CC (43)
Newly Matched Donor-Derived Fl-33 Car T Therapy Acute Myeloid Leukemia	Beijing GoBroad Hospital	P1	CC (43)
nkx101 - car nk cell therapy Acute Myeloid Leukemia	Nkarta, Inc.	P1	CC (43)
Nms-03597812 Acute Myeloid Leukemia	Nerviano Medical Sciences	P1	CC (43)
ntq2494 Acute Myeloid Leukemia	Nanjing Chia-tai Tianqing Pharmaceutical	P1	CC (43)
Onkord® Acute Myeloid Leukemia	Glycostem Therapeutics BV	P1/2	CC (43)
Pbsc Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2	CC (43)
Pcna Inhibitor Aoh1996 Acute Myeloid Leukemia	City of Hope Medical Center	P1	CC (43)
Pelcitoclax Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1/2	CC (43)
Prior-Hsct Donor-Derived Fl-33 Car T Therapy Acute Myeloid Leukemia	Beijing GoBroad Hospital	P1	CC (43)
Rabbit Anti-Thymocyte Globulin Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CC (43)
Ratg Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CC (43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta Acute Myeloid Leukemia	Mayo Clinic	P1	CC (43)
Retinol Acute Myeloid Leukemia	St. Petersburg State Pavlov Medical University	P2	CC (43)
sar445419 Acute Myeloid Leukemia	Sanofi	P1	CC (43)
shr2554 Acute Myeloid Leukemia	The First Affiliated Hospital of Soochow University	P2	CC (43)
Tak-243 Acute Myeloid Leukemia	National Cancer Institute (NCI)	P1	CC (43)
Tazemetostat Acute Myeloid Leukemia	Thomas Jefferson University	P1	CC (43)
Tcr Alpha Beta / Cd19+ Depleted Haploidentical Hematopoietic Progenitor Cell Graft Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CC (43)
Tcr Transduced T-Cells Acute Myeloid Leukemia	National Cancer Institute (NCI)	P1	CC (43)
Tranexamic Acid Acute Myeloid Leukemia	University of Manitoba	P2	CC (43)
Treg-Enriched Donor Cell Acute Myeloid Leukemia	Dana-Farber Cancer Institute	P1	CC (43)
trx103 Acute Myeloid Leukemia	Tr1X, Inc.	P1	CC (43)
Ucart123V1.2 Acute Myeloid Leukemia	Cellectis S.A.	P1	CC (43)
Venclyxto Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	P2	CC (43)
Ysnvz Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1	CC (43)
cd33 car-nk cell Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	CC (42)
cd33/cll1 dual car-nk cell Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	CC (42)
ctx131 Acute Myeloid Leukemia	CRISPR Therapeutics	P1/2	CC (42)
E-7820 Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CC (42)
Rabeprazole, Acute Myeloid Leukemia	Lomond Therapeutics Holdings, Inc.	P1	CC (42)

Showing 301 to 350 of 588 assets

PreviousPage 7 of 12Next